We are pleased to announce that effective July 3rd 2007, Medical Economics Research Group GmbH (MERG) has become part of IMS Health. This is an exciting development that will enable us to accelerate our provision and commitment to quality services for the pharmaceutical and health care industry; health economics and outcomes research expertise is seen by us as a key area.
MERG has wide experience in strategic consultancy, health economics, observational studies and health policy at a local, national and international level and number as customers big pharma and biotech companies; public and private health institutions; patients' associations, public and private groups of health research and food industry.
An important part of our strategy is to broaden our consulting capabilities in the Health Economics and Outcomes Research area. MERG joins over 140 specialists from recent acquisitions ValueMedics, HOR Europe, CORE, Fricke & Pirk, M-TAG, GYD and HEDM in the HEOR expertise area of IMS Consulting and Services.
IMS is committed to continue delivering high value services to all our customers as a result of this union and are confident the combined capabilities and expertise of MERG and IMS will provide an even stronger, broader range of solutions to support their businesses.
If you have any questions about this exciting development, please do not hesitate to call us on the numbers below.
Karin Berger
Principal Health Economics & Outcomes Research
Tel: +49 (0)89 / 45 79 12-0
Tina LambertVice President Global HEOR
Tel: +44(0)20 7393 5207